NASDAQ · PGNY
Healthcare · Medical - Healthcare Information Services
$27.76
Down-$0.11 (-0.40%)
Updated Sep 16, 2026, 4:27 PM
SID Score
6.6/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
PGNY closed at $27.76 after 20 trading sessions, up 7.97% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $27.88 | $27.91 | $27.58 | $27.76 | 690.8K |
| Sep 14, 2026 | $27.69 | $27.98 | $27.42 | $27.85 | 1.06M |
| Sep 11, 2026 | $27.45 | $27.7699 | $27.315 | $27.35 | 1.24M |
| Sep 10, 2026 | $26.94 | $27.60 | $26.94 | $27.08 | 894.61K |
| Sep 9, 2026 | $26.74 | $27.22 | $26.475 | $27.12 | 1.12M |
| Sep 8, 2026 | $26.00 | $27.61 | $25.87 | $27.15 | 1.85M |
| Sep 4, 2026 | $26.51 | $26.665 | $25.82 | $25.94 | 1.06M |
| Sep 3, 2026 | $26.47 | $26.765 | $26.08 | $26.61 | 708.4K |
| Sep 2, 2026 | $25.71 | $26.63 | $25.71 | $26.29 | 1.03M |
| Sep 1, 2026 | $25.49 | $26.09 | $25.46 | $25.66 | 765.24K |
| Aug 31, 2026 | $25.98 | $26.101 | $25.47 | $25.59 | 911.93K |
| Aug 28, 2026 | $25.96 | $26.2599 | $25.89 | $26.00 | 832.67K |
| Aug 27, 2026 | $26.26 | $26.49 | $25.70 | $25.86 | 1.16M |
| Aug 26, 2026 | $25.60 | $26.47 | $25.60 | $26.37 | 1.12M |
| Aug 25, 2026 | $25.51 | $25.855 | $25.368 | $25.82 | 1.41M |
| Aug 24, 2026 | $25.65 | $25.895 | $25.34 | $25.45 | 815.36K |
| Aug 21, 2026 | $26.08 | $26.266 | $25.24 | $25.65 | 1.08M |
| Aug 20, 2026 | $26.14 | $26.59 | $25.805 | $25.96 | 1.14M |
| Aug 19, 2026 | $25.60 | $25.895 | $25.41 | $25.53 | 867.4K |
| Aug 18, 2026 | $25.63 | $26.01 | $25.57 | $25.71 | 995.7K |
The latest Smart Investors Daily articles mentioning PGNY.
PGNY research
Company profile and research snapshot.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 8, 2026 | Citizens | Market Outperform | — |
| Aug 21, 2026 | JP Morgan | Neutral | — |
| Aug 20, 2026 | Wells Fargo | Overweight | — |
| Aug 13, 2026 | Truist Securities | Buy | — |
| Aug 12, 2026 | Barclays | Equal-Weight | — |
No generated briefing is available yet.
Yahoo · Sep 10, 2026
Let’s dig into the relative performance of Progyny (NASDAQ:PGNY) and its peers as we unravel the now-completed Q2 health insurance providers earnings season.
Yahoo · Sep 9, 2026
The mean of analysts' price targets for Progyny (PGNY) points to a 25.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Benzinga · Sep 8, 2026
Citizens analyst Constantine Davides maintains Progyny (NASDAQ:PGNY) with a Market Outperform and raises the price target from $31 to $33.
SeekingAlpha · Sep 5, 2026
Progyny, Inc. offers fertility benefits management, growing eligible members to 7.2 million and posting steady revenue and EPS growth. Click for more on PGNY.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning PGNY.
